Category: Financial News

Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Six Months Ended 30 June 2018
Press Release -

Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Six Months Ended 30 June 2018

Parnell delivers 32% revenue growth and a $4.0 million improvement in EBITDA in the first six months of 2018 compared to the same period in 2017, returns to profitability for the first time post-IPO and increases 2018 guidance to a 35% - 40% increase in revenue to $26 - $27 million and an EBITDA range of $5.5 - $6.5 million.